Mickaël Bourgeois

1.4k total citations
45 papers, 996 citations indexed

About

Mickaël Bourgeois is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mickaël Bourgeois has authored 45 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Radiology, Nuclear Medicine and Imaging, 14 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mickaël Bourgeois's work include Radiopharmaceutical Chemistry and Applications (33 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Peptidase Inhibition and Analysis (8 papers). Mickaël Bourgeois is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (33 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Peptidase Inhibition and Analysis (8 papers). Mickaël Bourgeois collaborates with scholars based in France, Switzerland and United States. Mickaël Bourgeois's co-authors include Michel Chérel, Alain Faivre-Chauvet, Françoise Kraeber‐Bodéré, Jacques Barbet, Caroline Bodet‐Milin, Clément Bailly, François Guérard, Marie Mougin‐Degraef, Jean‐François Gestin and Nicolas Lepareur and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and International Journal of Pharmaceutics.

In The Last Decade

Mickaël Bourgeois

44 papers receiving 980 citations

Peers

Countries citing papers authored by Mickaël Bourgeois

Since Specialization

Citations

This map shows the geographic impact of Mickaël Bourgeois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mickaël Bourgeois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mickaël Bourgeois more than expected).

Fields of papers citing papers by Mickaël Bourgeois

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mickaël Bourgeois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mickaël Bourgeois. The network helps show where Mickaël Bourgeois may publish in the future.

Co-authorship network of co-authors of Mickaël Bourgeois

This figure shows the co-authorship network connecting the top 25 collaborators of Mickaël Bourgeois. A scholar is included among the top collaborators of Mickaël Bourgeois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mickaël Bourgeois. Mickaël Bourgeois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Survival impact of [225Ac]Ac-DOTATOC alpha-therapy in a preclinical model of pancreatic neuroendocrine tumor liver micrometastases 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Nicolas Chouin, (unknown), (unknown), Séverine Marionneau‐Lambot, Sébastien Gouard, Éric Frampas, Alain Faivre-Chauvet, Mickaël Bourgeois, Aliyah Morgenstern, Frank Bruchertseifer, Michel Chérel, Françoise Kraeber‐Bodéré, C. Ansquer, Joëlle Gaschet	5
2	Clinical Advances and Perspectives in Targeted Radionuclide Therapy 2023 ·Pharmaceutics ·Nicolas Lepareur, (unknown), Marie Mougin‐Degraef, Mickaël Bourgeois	29
3	Prospective Multicentric Assessment of 68Ga-DOTANOC PET/CT in Grade 1-2 GEP-NET 2023 ·Cancers ·(unknown), Éric Frampas, Yann Touchefeu, Éric Mirallié, M. Le Bras, Hélène Senellart, A. Rauscher, (unknown), L. Campion, V. Rohmer, Olivier Couturier, Rachida Lebtahi, François Rouzet, Philippe Ruszniewski, Françoise Kraeber‐Bodéré, Mickaël Bourgeois, C. Ansquer	4
4	Immuno-PET: Design options and clinical proof-of-concept 2022 ·Frontiers in Medicine ·(unknown), Clément Bailly, Michel Chérel, Caroline Rousseau, Françoise Kraeber‐Bodéré, Caroline Bodet‐Milin, Mickaël Bourgeois	12
5	Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study 2021 ·Journal of Nuclear Medicine ·Caroline Bodet‐Milin, Alain Faivre-Chauvet, Thomas Carlier, C. Ansquer, A. Rauscher, Éric Frampas, Frédérique Toulgoat, Damien Masson, Mickaël Bourgeois, (unknown), V. Rohmer, Olivier Couturier, D. Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet, Françoise Kraeber‐Bodéré	15
6	Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·Yann Touchefeu, Clément Bailly, Éric Frampas, (unknown), Caroline Rousseau, Mickaël Bourgeois, Céline Bossard, Alain Faivre-Chauvet, A. Rauscher, Damien Masson, (unknown), (unknown), Thomas Carlier, Robert M. Sharkey, David M. Goldenberg, Jacques Barbet, Françoise Kraeber‐Bodéré, Caroline Bodet‐Milin	23
7	SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human 2020 ·Frontiers in Oncology ·(unknown), (unknown), Frédérique Nguyen, Karine Bernardeau, Catherine Maurel, Caroline Bodet‐Milin, (unknown), Jérôme Abadie, Valérie Gouilleux‐Gruart, Aurélien Vidal, Mickaël Bourgeois, Nicolas Chouin, Catherine Ibisch, François Davodeau	1
8	Imaging of Monoclonal Gammapathy of Undetermined Significance and Smoldering Multiple Myeloma 2020 ·Cancers ·Bastien Jamet, Clément Bailly, Thomas Carlier, Cyrille Touzeau, (unknown), Mickaël Bourgeois, Philippe Moreau, Caroline Bodet‐Milin, Françoise Kraeber‐Bodéré	6
9	ARRONAX Cyclotron: Setting up of In‐House Hospital Radiopharmacy 2020 ·BioMed Research International ·Aurélien Vidal, (unknown), (unknown), (unknown), Férid Haddad, Alain Faivre-Chauvet, Mickaël Bourgeois	2
10	What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between 89Zr- and 64Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model 2019 ·International Journal of Molecular Sciences ·Clément Bailly, Sébastien Gouard, François Guérard, (unknown), Thomas Carlier, Alain Faivre-Chauvet, (unknown), Mickaël Bourgeois, Nicolas Chouin, Latifa Rbah‐Vidal, Raphaël Tripier, Férid Haddad, Françoise Kraeber‐Bodéré, Caroline Bodet‐Milin, Michel Chérel	23
11	TE1PA as Innovating Chelator for ⁶⁴Cu Immuno-TEP Imaging: A Comparative in Vivo Study with DOTA/NOTA by Conjugation on 9E7.4 mAb in a Syngeneic Multiple Myeloma Model 2019 ·Bioconjugate Chemistry ·(unknown), (unknown), (unknown), Nathalie Le Bris, Clément Bailly, Catherine Saï-Maurel, Mickaël Bourgeois, Michel Chérel, Raphaël Tripier, Alain Faivre-Chauvet	22
12	Potential for Nuclear Medicine Therapy for Glioblastoma Treatment 2019 ·Frontiers in Pharmacology ·Clément Bailly, Aurélien Vidal, (unknown), Françoise Kraeber‐Bodéré, Michel Chérel, Amandine Pallardy, Caroline Rousseau, Emmanuel Garcion, Franck Lacœuille, François Hindré, Samuel Valable, Myriam Bernaudin, Caroline Bodet‐Milin, Mickaël Bourgeois	36
13	Hypoxia Imaging and Adaptive Radiotherapy: A State-of-the-Art Approach in the Management of Glioma 2019 ·Frontiers in Medicine ·(unknown), Aurélien Corroyer‐Dulmont, Paul Lesueur, (unknown), Michel Chérel, Mickaël Bourgeois, Dinu Stefan, Elaine Johanna Limkin, Cécile Perrio, Jean‐Sébastien Guillamo, Bernard Dubray, Myriam Bernaudin, Juliette Thariat, Samuel Valable	45
14	Radioimmunotherapy for Treatment of Acute Leukemia 2016 ·Seminars in Nuclear Medicine ·Caroline Bodet‐Milin, Françoise Kraeber‐Bodéré, Thomas Eugène, François Guérard, Joëlle Gaschet, Clément Bailly, Marie Mougin‐Degraef, Mickaël Bourgeois, Alain Faivre-Chauvet, Michel Chérel, Patrice Chevallier	25
15	²¹³Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma 2013 ·Journal of Nuclear Medicine ·Michel Chérel, Sébastien Gouard, Joëlle Gaschet, Catherine Saï-Maurel, Frank Bruchertseifer, Aliyah Morgenstern, Mickaël Bourgeois, Jean‐François Gestin, Françoise Kraeber‐Bodéré, Jacques Barbet, Philippe Moreau, François Davodeau	58
16	Radioiodinated and astatinated NHC rhodium complexes: Synthesis 2013 ·Nuclear Medicine and Biology ·(unknown), François Guérard, Marie Mougin‐Degraef, Mickaël Bourgeois, (unknown), Michel Chérel, Jacques Barbet, Alain Faivre-Chauvet, Jean‐François Gestin	14
17	Radiolabeled Antibodies for Cancer Imaging and Therapy 2012 ·Methods in molecular biology ·Jacques Barbet, Manuel Bardiès, Mickaël Bourgeois, Jean‐François Chatal, Michel Chérel, François Davodeau, Alain Faivre-Chauvet, Jean‐François Gestin, Françoise Kraeber‐Bodéré	62
18	Contribution of [64Cu]-ATSM PET in molecular imaging of tumour hypoxia compared to classical [18F]-MISO — a selected review 2011 ·Nuclear Medicine Review ·Mickaël Bourgeois, (unknown), François Guérard, Marie Mougin‐Degraef, Jacques Barbet, Nathalie Michel, Michel Chérel, Alain Faivre-Chauvet	57
19	Feasibility of the radioastatination of a monoclonal antibody with astatine‐211 purified by wet extraction 2008 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Mickaël Bourgeois, François Guérard, Cyrille Alliot, Marie Mougin‐Degraef, (unknown), (unknown), Jean‐François Gestin, François Davodeau, Michel Chérel, Jacques Barbet, (unknown)	19
20	Purification of [18F]-fluoro-l-thymidine ([18F]-FLT) for positron emission tomography imaging 2007 ·Journal of Pharmaceutical and Biomedical Analysis ·Mickaël Bourgeois, Marie Mougin‐Degraef, (unknown), Michel Chérel, Jean‐François Gestin, Didier Le Bars, Jacques Barbet, Alain Faivre-Chauvet	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact